MXCT

MaxCyte Inc

NASDAQ: MXCT · HEALTHCARE · MEDICAL DEVICES

$1.24

+1.64% today

Updated 2026-09-22

Market cap

$121.78M

P/E ratio

—

P/S ratio

3.92x

EPS (TTM)

$-0.34

Dividend yield

—

52W range

$1 – $2

Volume

0.7M

Market cap

$121.78M

P/E ratio

—

P/S ratio

3.92x

EPS (TTM)

$-0.34

Dividend yield

—

52W range

$1 – $2

Volume

0.7M

MaxCyte Inc (MXCT) Financial Forecast & Price Target 2030

Revenue-driven projection model with historical context.

Price target summary

Current price

$1.24

12-Month target

—

2030 Target

—

Intrinsic (DCF)

—

Financial forecast

Metric	2021	2022	2023	2024	2025
Revenue	$0.0B	$0.0B	$0.0B	$0.0B	$0.0B
EPS	—	—	—	—	—

CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -114.80%

Methodology

CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.